{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/dev.drugpolicy.ca\/fr\/","author_name":"Donald MacPherson","author_url":"https:\/\/dev.drugpolicy.ca\/fr\/author\/donaldm\/","title":"Toronto Drug Strategy Consumption Room Feasibility study released - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"uqmfbbsx0r\"><a href=\"https:\/\/dev.drugpolicy.ca\/fr\/toronto-drug-strategy-consumption-room-feasibility-study-released\/\">Toronto Drug Strategy Consumption Room Feasibility study released<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/dev.drugpolicy.ca\/fr\/toronto-drug-strategy-consumption-room-feasibility-study-released\/embed\/#?secret=uqmfbbsx0r\" width=\"600\" height=\"338\" title=\"&#8220;Toronto Drug Strategy Consumption Room Feasibility study released&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"uqmfbbsx0r\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/dev.drugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/dev.drugpolicy.ca\/wp-content\/uploads\/2012\/03\/CDPC_TOSCAreport_Blog_415x415px-S-1.jpg","thumbnail_width":415,"thumbnail_height":415,"description":"In 2005 when the Toronto Drug Strategy was approved by Toronto City Council one of the main recommendations was to complete a needs assessment and feasibility study on the implications of establishing supervised consumption sites in Toronto. The independent research project \u2013 expanded to include Ottawa \u2013 was carried out over four years by Dr. [&hellip;]"}